表紙
市場調査レポート

世界の動物用診断薬市場:製品、動物、地域別 - 動向および予測

Global Veterinary Diagnostics Market - By Products, By animal types & Geography - Trends & Forecasts- 2015-2020

発行 Mordor Intelligence LLP 商品コード 319380
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
世界の動物用診断薬市場:製品、動物、地域別 - 動向および予測 Global Veterinary Diagnostics Market - By Products, By animal types & Geography - Trends & Forecasts- 2015-2020
出版日: 2016年01月01日 ページ情報: 英文
概要

世界の動物用診断薬市場は2014年に15億9,000万米ドルとなる見込みです。動物用タンパク質の需要が伸び続けており、食品安全に関する法規制が厳格化していることが市場の拡大を促進しています。同市場は今後CAGR4.6%で堅調に拡大し、2019年までに20億2,000万米ドル規模になると予測されています。

当レポートでは、世界の動物用診断薬市場の動向と将来予測、市場に参入する主要企業の競合環境、市場シェア、近年の動向とともにプロファイルをまとめています。

第1章 イントロダクション

第2章 市場分析

  • 動物医療製品市場
  • 動物医療とヒトの医療

第3章 市場動向

  • 市場促進因子
    • ペット所有率の上昇
    • 栄養の改善
    • 食品安全に対する消費者の意識向上
    • 家畜生産の増大
    • 人畜共通感染症、食品媒介疾患
  • 市場阻害因子
    • 耕作地と水の不足
    • 耕地に関する競争激化
    • 費用対効果の高い生産
  • ポーターズファイブフォース分析

第4章 世界の動物用診断薬市場セグメンテーション

  • 製品別
    • イントロダクション
    • 免疫診断検査
  • 種類別
    • コンパニオンアニマル
    • 家畜
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域

第5章 競合環境

  • 市場における主要参入企業
  • 合併・買収
  • 新製品上市
  • 協定、連携、提携
  • 新規参入者への提言
  • 老舗企業への提言

第6章 企業プロファイル

  • Zoetis animal healthcare
  • Merck
  • Merial (Animal Health Division Of Sanofi)
  • Elanco
  • Bayer healthcare
  • Novartis Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim

第7章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

The Global Veterinary Diagnostics Market was valued at USD 2.66 billion in 2015 and is projected to reach USD 3.89 billion by 2020, at a CAGR of 7.78% during the forecast period from 2014 to 2019. The ever-rising demand for animal protein and stricter regulations concerning food safety will propel the market for diagnostics in animal healthcare.

Veterinary diagnostic products are as complex as they are difficult to manufacture. Many of the rapid assay, poultry, and livestock diagnostic products are biologic products, which require materials from living organisms. Owing to this, during the economic recession of 2008, the United States faced a decline in consumer spending on pets, which affected the veterinary diagnostics market. The market development for companion animal diagnostics has depended heavily upon the purchasing and usage of in-clinic analyzers or diagnostic instruments that are used for veterinary practices.

Diagnostic technologies, such as lateral flow and other rapid tests are used in veterinary medicine to test commercial livestock and household pets for the presence of a variety of medical conditions to undertake preventative or remedial measures. Food animal diagnostics assist in livestock, production, and animal preventive care while complementing other measures, such as vaccination and selective breeding.

In the global veterinary diagnostics market, molecular diagnostics represents a growing segment of the market with the laboratory utilization of polymerase chain reaction (PCR) and microarray tests.

The North American and European veterinary diagnostics markets have huge market shares owing to the increasing companion animal population coupled with the positive trend towards animal healthcare spending. Developing regions in Asia-pacific and Africa are expected to form a new revenue pocket in the market, with India, China and Brazil constituting a majority of market growth over the next decade.

The global veterinary diagnostics market is segmented by type of products into Enzyme Linked Immuno Sorbent Assay (ELISA), Rapid Immuno Migration (RIM), Diagnostic imaging, and Ultrasound Imaging, among others. The market is additionally segmented by type of animals into companion animals and farm animals. The report also covers the market by geography, studying diagnostics in North America, Asia-Pacific, Europe, and the Rest of the World. Pfizer (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), and Bioniche Animal Health Canada, Inc. (Canada) are the key players in the global veterinary diagnostics market.

Key Deliverables in the Study

  • 1. Market analysis for the Global Veterinary Diagnostics Market, with region specific assessments and competition analysis on global and regional scales
  • 2. Market definition along with the identification of key drivers and restraints
  • 3. Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale
  • 4. Extensively researched competitive landscape section with profiles of major companies along with their market shares
  • 5. Identification and analysis of the macro and micro factors that affect the global veterinary diagnostics market on both global and regional scales
  • 6. A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
  • 7. A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
  • 8. Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

Table of Contents

1. Introduction

  • 1.1. Study Deliverables
  • 1.2. Market Definition
  • 1.3. Sizing Units
  • 1.4. Base Currency
  • 1.5. Review and Forecast Period Years
  • 1.6. General Study Assumptions

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Analysis Methodology
  • 2.3. Econometric Forecast Model
  • 2.4. Research Assumptions

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry Trends

  • 5.1. Current Market Scenario
  • 5.2. Technology Overview
  • 5.3. New Developments
  • 5.4. Industry Value-Chain Analysis
  • 5.5. Product Life-Cycle Analysis
  • 5.6. Product Benchmarking
  • 5.7. Investment Analysis
  • 5.8. Porter's Five Forces
    • 5.8.1. Bargaining Power of Suppliers
    • 5.8.2. Bargaining Power of Consumers
    • 5.8.3. Threat of New Entrants
    • 5.8.4. Threat of Substitute Products and Services
    • 5.8.5. Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

  • 6.1. Market Drivers
    • 6.1.1. Increase in pet ownership
    • 6.1.2. Improved Nutrition
    • 6.1.3. Intensifying consumer focus on food safety
    • 6.1.4. Greater Livestock production
    • 6.1.5. Increasing Zoonotic and Foodborne Diseases
  • 6.2. Market Restraints
    • 6.2.1. Scarcity of arable land and water
    • 6.2.2. Increased competition for cultivated land
    • 6.2.3. Cost effective productio
  • 6.3. Key Challenges
  • 6.4. Current Opportunities in the Market

7. Market Segmentation

  • 7.1. By products
    • 7.1.2. Immunodiagnostic Tests
      • 7.1.2.1. Enzyme linked immuno-sorbent assay (ELISA)
      • 7.1.2.2. Rapid Immuno Migration (RIM™)
      • 7.1.2.3. Agar gel immuno-diffusion (AGID)
    • 7.1.3. Molecular Diagnostic Tests
      • 7.1.3.1. Polymerase Chain Reaction (PCR)
      • 7.1.3.2. Diagnostic Imaging
      • 7.1.3.3. Ultrasound Imaging
      • 7.1.3.4. Mri Scanning
  • 7.2. Global Veterinary Diagnostic Market, By species
    • 7.2.1. Companion Animals
      • 7.2.1.1. Dogs
      • 7.2.1.2. Cats
      • 7.2.1.3. Horses
    • 7.2.2. Farm animal
      • 7.2.2.1. Cattle
      • 7.2.2.2. Swine
      • 7.2.2.3. Poultry
      • 7.2.2.4. Fish
      • 7.2.2.5. Sheep
  • 7.3. By Geography
    • 7.3.1. North America (NA)
      • 7.3.1.1. United States
      • 7.3.1.2. Canada
      • 7.3.1.3. Mexico
      • 7.3.1.4. Rest of North America
    • 7.3.2. Europe
      • 7.3.2.1. Germany
      • 7.3.2.2. UK
      • 7.3.2.3. France
      • 7.3.2.4. Italy
      • 7.3.2.5. Spain & Portugal
      • 7.3.2.6. Scandinavia
      • 7.3.2.7. BENELUX
      • 7.3.2.8. Rest of Europe
    • 7.3.3. Asia-Pacific (APAC)
      • 7.3.3.1. China
      • 7.3.3.2. Japan
      • 7.3.3.3. India
      • 7.3.3.4. Australia & New Zealand
      • 7.3.3.5. South Korea
      • 7.3.3.6. Rest of APAC
    • 7.3.4. Middle-East and Africa (MEA)
      • 7.3.4.1. GCC
      • 7.3.4.2. Egypt
      • 7.3.4.3. South Africa
      • 7.3.4.4. Morocco
      • 7.3.4.5. Algeria
      • 7.3.4.6. Rest Of MEA
    • 7.3.3. Latin America
      • 7.3.3.1. Brazil
      • 7.3.3.2. Argentina
      • 7.3.3.3. Rest of Latin America

8. Competitive Landscape

  • 8.1. Mergers & Acquisitions
  • 8.2. New Product Launches
  • 8.3. Agreements, Collaborations & Partnerships

9. Key Vendor Analysis

  • 9.1. Idexx
  • 9.2. Abaxis Inc
  • 9.3. Thermo Fisher Scientific
  • 9.4. VCA Antech
  • 9.5. Henry Schein
  • 9.6. Virbac
  • 9.7. Zoetis
  • 9.8. Biochek
  • 9.9. IDVet
  • 9.10. Pfizer

10. Analyst Outlook for Investment Opportunities

11. Future Outlook of the Market

Back to Top